mylan

March 5, 2015March 6, 2015

Gilead Hands Over Sofosbuvir Distribution in India to Mylan

Hepatitis C, News

The Indian subsidiary of Mylan Inc. has signed an agreement with biopharmaceutical company Gilead Sciences to receive the rights as exclusive distributor in India of both Sovaldi and Harvoni — therapies designed to treat ... Read more

January 29, 2015January 29, 2015

Mylan Launches Generic Epivir-HBV® by GSK for Hepatitis B

News

Mylan Inc. announced the United States launch of their generic formulation of GlaxoSmithKline’s Epivir-HBV® Lamivudine Tablets, 100 mg. The company received the FDA’s final approval for its Abbreviated New Drug Application (ANDA), appropriated for ... Read more